Pfcrt 76T and pfmdr1 86Y allele frequency in Plasmodium falciparum isolates and use of self-medication in a rural area of Gabon

Trans R Soc Trop Med Hyg. 2014 Nov;108(11):729-34. doi: 10.1093/trstmh/tru147. Epub 2014 Sep 23.

Abstract

Background: Studies showed that chloroquine resistance may revert to sensitivity after its withdrawal mainly detected by a significant decrease of Plasmodium falciparum pfcrt 76T and pfmdr1 86Y alleles. Besides, self-medication is considered as a key factor of antimalarial drug resistance expansion. Thus, pfcrt 76T and pfmdr1 86Y allele frequency and its relationship with antimalarial drug self-medication was analyzed in P. falciparum isolates collected in Gabon.

Methods: Samples were collected from febrile children screened for P. falciparum infection in 2005 and 2008 at the regional hospital of Oyem. Self-use of antimalarial drugs before the day of consultation was recorded. Polymorphic codons 76 and 86 of pfcrt and pfmdr1 genes were analyzed by PCR-RFLP.

Results: The frequency of pfcrt 76T mutant allele was greater than 70.0% in 2005 and 2008. Wild type isolates were 1.7-fold more prevalent in 2008. The prevalence of pfmdr1 86Y mutant allele was comparable between 2005 and 2008 (p=0.1); the proportion of wild type allele reached 20.5% in 2008. The frequency of wild type allele pfcrt K76 or pfmdr1 N86 was higher among patients without anti-malarial drug self-medication compared to those who used it.

Conclusions: An increase of the frequency of P. falciparum wild type allele pfcrt 76K and pfmdr1 86N was observed within a short period after chloroquine withdrawal. The proportion of mutant genotypes is still high, mainly among patients using self-medication with antimalarial drugs.

Keywords: Gabon; Pfcrt gene; Pfmdr1 gene; Plasmodium falciparum; Resistance; Self-medication.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amodiaquine / adverse effects
  • Amodiaquine / pharmacology
  • Amodiaquine / therapeutic use
  • Antimalarials / adverse effects
  • Antimalarials / pharmacology*
  • Antimalarials / therapeutic use
  • Child
  • Child, Preschool
  • Chloroquine / adverse effects
  • Chloroquine / pharmacology
  • Chloroquine / therapeutic use
  • Drug Resistance / genetics*
  • Female
  • Gabon / epidemiology
  • Gene Frequency*
  • Humans
  • Infant
  • Malaria, Falciparum / drug therapy*
  • Malaria, Falciparum / parasitology*
  • Male
  • Membrane Transport Proteins
  • Multidrug Resistance-Associated Proteins
  • Plasmodium falciparum / drug effects
  • Plasmodium falciparum / genetics*
  • Protozoan Proteins
  • Rural Population
  • Self Medication / statistics & numerical data

Substances

  • Antimalarials
  • Mdr1 protein, Plasmodium falciparum
  • Membrane Transport Proteins
  • Multidrug Resistance-Associated Proteins
  • PfCRT protein, Plasmodium falciparum
  • Protozoan Proteins
  • Amodiaquine
  • Chloroquine